Profile
Astorg is a private equity firm based in Europe, with offices in London, Paris, New York, Milan, Frankfurt, and Luxembourg. Founded in 1998, Astorg is known for its collaborative and listening approach to investments. The firm is led by Executive Chairman Thierry Timsit and boasts a skilled team committed to fostering long-term partnerships with their portfolio companies.
Astorg focuses on sectors such as software, healthcare, business services, and technology-based industrial companies. With an impressive €24 billion in assets under management, the firm typically invests in mid to large-cap companies across Europe and the US, targeting value creation through strategic guidance and capital support.
Notable companies in Astorg's portfolio include IPL - infection prevention devices; Solabia - biotech ingredients; Attikon - insurance brokerage; Redslim - data management for CPG and CHC markets; and Nexpring Health - Assisted Reproductive Technology specialist.
Industry
Astorg Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Normec Continuation Fund
|
Fund of funds
|
Business Services (B2B)
Financial Services
Fintech
Healthcare Services
Industrial
MedTech
|
Seed
Series A
Series B
|
North America
Europe
|
$5-10 m
|
$1400 M
|
July 2024
|
|
Astorg VIII
|
Private Equity (PE)
|
Business Services (B2B)
Financial Services
Fintech
Healthcare Services
MedTech
|
Series B
Late Stage (Series C+)
|
North America
Europe
|
$5-10 m
|
$4400 M
|
May 2024
|
|
Astorg Mid-Cap Fund I
|
Private Equity (PE)
|
Business Services (B2B)
Financial Services
Fintech
Healthcare Services
SaaS
Software
|
Series B
Late Stage (Series C+)
|
North America
Europe
|
$5-10 m
|
$1300 M
|
February 2022
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.